Navigating the Frontier of IRDs: Expert Perspectives on Luxturna Outcomes, Genotype Stratification, and AI-Driven Trial Endpoints
Session on inherited retinal diseases and paediatrics featured talks addressing unmet needs, updates on outcomes of patients treated with voretigene neparvovec gene therapy, and new insights about select genetic diseases.











